Dma/RNF8 proteins are evolutionarily conserved E3 ubiquitin ligases that target septins.
Taylor & Francis
Copyright © 2013 Landes Bioscience. This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited.
The budding yeast proteins Dma1 and Dma2 are members of the unique FHA-RING domain protein family and are linked to mitotic regulation and septin organization by ill-defined mechanisms. We show that Dma2 has ubiquitin ligase activity, and that septins Shs1 and Cdc11 are likely direct in vivo targets. We further propose that human RNF8, rather than Chfr, is the mammalian Dma homolog. As in yeast, RNF8 localizes to the centrosomes and cell division sites and promotes ubiquitylation of the septin SEPT7, whose depletion increases cell division anomalies. Together, these findings reveal evolutionary and functional conservation of Dma proteins, and suggest that RNF8 maintains genome stability through independent, yet analogous, nuclear and cytoplasmic ubiquitylation activities.
European Community’s Seventh Framework Program
Research Support, Non-U.S. Gov't
Vol. 12, Iss. 6, pp. 1000 - 1008
Place of publication
Showing items related by title, author, creator and subject.
Chahwan, R; Gravel, S; Matsusaka, T; Jackson, SP (Taylor & Francis, 2013-04-02)N/A
IKKbeta programs to turn on the GADD45alpha-MKK4-JNK apoptotic cascade specifically via p50 NF-kappaB in arsenite response Song, L; Li, J; Zhang, D; Liu, ZG; Ye, J; Zhan, Q; Shen, HM; Whiteman, Matthew; Huang, C (Rockefeller University Press, 2006-11-20)Cross talk between NF-kappaB and c-Jun N-terminal kinases (JNKs) has been implicated in the cell life and death decision under various stresses. Functional suppression of JNK activation by NF-kappaB has recently been ...
Murton, AJ; Maddocks, M; Stephens, FB; Marimuthu, K; England, R; Wilcock, A (Elsevier, 2016-06-25)INTRODUCTION: The loss of muscle is common in patients with advanced non-small-cell lung cancer (NSCLC) and contributes to the high morbidity and mortality of this group. The exact mechanisms behind the muscle loss are ...